Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (81-90 of 204) with videos related to

Pageof 21
Sort By:
International Journal of Oncology|November 8, 2006
The hollow fibre model--facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfareMarie Suggitt, Patricia A Cooper, Steven D Shnyder, et al.
International Journal of Oncology|July 31, 1998
Microsatellite instability, chemosensitivity and mutant frequency in a series of 1,2-dimethylhydrazine induced murine colon adenocarcinoma modelsM J Thompson, R Slack, J A Double, et al.
British Journal of Cancer|November 1, 1996
Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancerA M Burger, J A Double, J Konopa, et al.
British Journal of Cancer|June 1, 1995
EO9: relationship between DT-diaphorase levels and response in vitro and in vivoJ Collard, A M Matthew, J A Double, et al.
Anticancer Research|January 1, 1997
Morphological and immunological observations on the effects of hexadecylphosphocholine (HPC) in nude mice bearing MT-1 breast cancer xenograftsO Safa, S M Parkin, A M Matthew, et al.
BMJ Open|September 10, 2016
What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UKAnna C Bibby, Katie Williams, Sarah Smith, et al.
Anti-Cancer Drug Design|April 1, 1986
Nucleoside analogues. 5. Molecular combination of anti-cancer drugs: activity of 5-fluorouracil/nitrosourea combinations against mouse colon tumoursJ A Double, M C Bibby, J E McCormick, et al.
International Journal of Radiation Biology|July 1, 1991
Flavone acetic acid: is vascular shutdown the crucial mechanism of actionM C Bibby, J A Double, R M Phillips, et al.
British Journal of Cancer|March 1, 1993
Pre-clinical evaluation of a novel chloroethylating agent, ClomesoneA M Matthew, R M Phillips, P M Loadman, et al.
British Journal of Cancer|August 1, 1992
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumoursP K Quinn, M C Bibby, J A Cox, et al.
Pageof 21

Showing results (81-90 of 204) with videos related to

Sort By:
Pageof 21
International Journal of Oncology|November 8, 2006
The hollow fibre model--facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfareMarie Suggitt, Patricia A Cooper, Steven D Shnyder, et al.
International Journal of Oncology|July 31, 1998
Microsatellite instability, chemosensitivity and mutant frequency in a series of 1,2-dimethylhydrazine induced murine colon adenocarcinoma modelsM J Thompson, R Slack, J A Double, et al.
British Journal of Cancer|November 1, 1996
Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancerA M Burger, J A Double, J Konopa, et al.
British Journal of Cancer|June 1, 1995
EO9: relationship between DT-diaphorase levels and response in vitro and in vivoJ Collard, A M Matthew, J A Double, et al.
Anticancer Research|January 1, 1997
Morphological and immunological observations on the effects of hexadecylphosphocholine (HPC) in nude mice bearing MT-1 breast cancer xenograftsO Safa, S M Parkin, A M Matthew, et al.
BMJ Open|September 10, 2016
What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UKAnna C Bibby, Katie Williams, Sarah Smith, et al.
Anti-Cancer Drug Design|April 1, 1986
Nucleoside analogues. 5. Molecular combination of anti-cancer drugs: activity of 5-fluorouracil/nitrosourea combinations against mouse colon tumoursJ A Double, M C Bibby, J E McCormick, et al.
International Journal of Radiation Biology|July 1, 1991
Flavone acetic acid: is vascular shutdown the crucial mechanism of actionM C Bibby, J A Double, R M Phillips, et al.
British Journal of Cancer|March 1, 1993
Pre-clinical evaluation of a novel chloroethylating agent, ClomesoneA M Matthew, R M Phillips, P M Loadman, et al.
British Journal of Cancer|August 1, 1992
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumoursP K Quinn, M C Bibby, J A Cox, et al.
Pageof 21